<DOC>
	<DOCNO>NCT00003078</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining radiation therapy chemotherapy may kill tumor cell . It know whether receive radiation therapy plus cisplatin effective receiving radiation therapy plus fluorouracil treating patient cancer cervix . PURPOSE : Randomized phase III trial compare effectiveness radiation therapy plus cisplatin fluorouracil treat patient primary stage IIB , stage IIIB , stage IVA cancer cervix .</brief_summary>
	<brief_title>Radiation Therapy With Without Cisplatin Fluorouracil Treating Patients With Cancer Cervix</brief_title>
	<detailed_description>OBJECTIVES : I . Compare progression-free survival survival patient advanced cervical cancer limit pelvis receive either radiotherapy alone , radiotherapy plus weekly cisplatin , radiotherapy plus prolonged venous infusion ( PVI ) fluorouracil . [ Radiotherapy alone regimen close 8/18/98 ] II . Determine relative toxic effect radiation therapy plus chemotherapy either weekly cisplatin PVI fluorouracil compare radiation alone . [ Radiotherapy alone regimen close 8/18/98 ] IV . Compare progression-free survival survival patient advanced cervical cancer limit pelvis smoke time diagnosis versus non-smokers smoke radiation therapy versus quit . OUTLINE : This randomize study . Patients stratified stage , performance para-aortic lymphadenectomy , brachytherapy method ( HDR v LDR ) . Prior treatment patient complete questionnaire regard past present smoke history exposure secondhand smoke . In arm I , patient undergo external radiation therapy pelvis daily 5 time week 5 week . Then , patient receive either low dose rate high dose rate intracavitary brachytherapy one two application 5 fraction twice week , respectively . If intracavitary radiation therapy perform , shrink field technique execute . In addition , patient receive parametrial boost daily 3 5 day intracavitary brachytherapy . Concurrently , patient receive IV cisplatin week 5 week begin day 1 external radiation therapy parametrial boost . Patients arm II receive external radiation therapy brachytherapy previously describe . [ Arm II close 8/18/98 ] In arm III , patient undergo external radiation therapy describe arm I . In addition , patient receive prolong venous infusion ( PVI ) fluorouracil daily 5 day external beam radiation therapy ( whole pelvis parametrial boost ) . If 6 course cisplatin fluorouracil administer external radiation therapy , sixth course chemotherapy give brachytherapy . Patients follow every 3 month first 2 year , every 6 month next 3 year , annually death . PROJECTED ACCRUAL : This study accrue maximum 870 patient 66 month .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Primary , previously untreated , histologically confirm invasive squamous cell carcinoma , adenocarcinoma , adenosquamous carcinoma uterine cervix stage IIB , IIIB , IVA Negative paraaortic lymph node determine lymphangiogram , CT , MRI , lymphadenectomy ( exclude suspicious paraaortic lymph node ) Paraaortic lymphadenectomy must perform extraperitoneally laparoscopy No histologically confirm cancer involve paraaortic lymph node , intraperitoneal disease , positive peritoneal cytology No recurrent invasive carcinoma uterine cervix , regardless previous treatment cervix cancer squamous cell , adenosquamous , adenocarcinoma No carcinoma cervical stump PATIENT CHARACTERISTICS : Age : Any age Performance status : GOG 03 Life expectancy : Not specify Hematopoietic : WBC least 3,000/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 1.5 time normal SGOT alkaline phosphatase great 3 time normal Renal : Creatinine great 2.0 mg/dL Other : No septicemia severe infection Not pregnant Negative pregnancy test Effective contraception require fertile patient No invasive malignancy unless disease free least 5 year prior cancer treatment contraindicate protocol therapy No concomitant malignancy nonmelanomatous skin cancer Must complete smoking history questionnaire provide urine specimen cotinine analysis PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior cytotoxic chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiation therapy pelvis Surgery : No prior hysterectomy</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>stage III cervical cancer</keyword>
	<keyword>stage IIB cervical cancer</keyword>
	<keyword>stage IVA cervical cancer</keyword>
	<keyword>cervical squamous cell carcinoma</keyword>
	<keyword>cervical adenocarcinoma</keyword>
	<keyword>cervical adenosquamous cell carcinoma</keyword>
</DOC>